Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Overview of attention for article published in Nature Medicine, September 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 3 X users

patent: 10 patents

Citations

dimensions_citation: 522 Dimensions

Readers on

mendeley: 205 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,547 followers.

RT @TomislavCaval: One of the classic #glycotime examples O-glycosylation of death receptors 4 and 5 in cancer cells modulates sensitivity…

14 Oct 2019

Reply Repost Favourite

RT @TomislavCaval: One of the classic #glycotime examples O-glycosylation of death receptors 4 and 5 in cancer cells modulates sensitivity…

14 Oct 2019

Reply Repost Favourite

One of the classic #glycotime examples O-glycosylation of death receptors 4 and 5 in cancer cells modulates sensitivity to Apo2L(TRAIL) by promoting receptor clustering and caspase 8 activation https://t.co/QKspAuXuEV

14 Oct 2019

Reply Repost Favourite